Sun Pharmaceuticals – Recall of Riomet ER™ (metformin)
September 23, 2020 - Sun Pharmaceuticals announced a voluntary, consumer-level recall of one lot of Riomet ER (metformin) extended release oral suspension due to the level of N-Nitrosodimethylamine (NDMA), which has been found to be above the allowable Acceptable Daily Intake (ADI) limit established by the FDA.
Top